Berry Genomics

Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.

Berry Genomics, founded in May, 2010 and headquartered in Chengdu, is a gene sequencing in the field of clinical translation company. The founder is Gao Yang. Listed on the SZSE on April 22, 1997, the company's major shareholders are Gao Yang, Chengdu Tianxing Instrument and Meter Co.,Ltd. and Tianjin Junruiqi Equity Investment Partnership (LP). Rivals that have direct and indirect competition with Berry Genomics include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Biotech

Founded

May 18, 2010

HQ location

Sichuan, China

Legal name

Berry Genomics Co., Ltd.

Employees

1608

See more